Sixfold Bioscience
We are the architects of targeted RNA.
Sixfold Bioscience has raised €9.2M across 1 funding round from 5 investors, most recently a Seed round in Dec 2021. Based in London, UK; active in Healthtech. Data as of Nov 2026.
London, UKwww.sixfold.bio ↗
Total raised
€9.2M
€9,162,673
Funding rounds
1
Investors
5
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearSixfold Bioscience — funding by year — interactive chart.
Data table
| Sixfold Bioscience — funding by year | |
|---|---|
| 2021 | €9.2M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round- 2021-12-06Seed€9.2MAngel Investors,Cantos Ventures,Lombard Street Ventures,Pi Campus+1 more
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-06 | Seed | €9.2M | Angel Investors,Cantos Ventures,Lombard Street Ventures,Pi Campus,Y Combinator | View deal → |
Investors
5Related news
Similar companies
same sector, similar size- Charco Neurotech€8.8MUK · Healthtech
- LoQus23 Therapeutics€8.3MUK · Healthtech
- Base Genomics€9.8MUK · Healthtech
- PharmEnable€9.0MUK · Healthtech
- Vine Health€6.2MUK · Healthtech
- Epitopea€12MUK · Healthtech
Global coverage: FundingData